Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-01-13
1990-10-16
Lipovsky, Joseph A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514552, A61K 3156, A61K 3123
Patent
active
049635409
ABSTRACT:
A pharmaceutical composition suitable for oral administration comprises micronized progesterone in an oil vehicle which is high in glycerides of polyunsaturated fatty acids. Micronized progesterone particles suspended in such an oil vehicle are absorbed more readily into the bloodstream and achieve high progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of premenstrual syndrome.
REFERENCES:
patent: 4073960 (1978-02-01), Scott et al.
patent: 4196188 (1980-04-01), Besins
patent: 4349530 (1982-09-01), Royer
patent: 4512986 (1985-04-01), Reel et al.
Chemical Abstracts, vol. 52 (1958), #17632g, Middendorf.
Morville et al., J. Gyn. Obst. Biol. Repr., 1982, 11, 355-363.
Gonzalez, JAMA, Apr. 10, 1981, vol. 245, No. 14, p. 1394.
Ottosson et al., Acta. Obstet. Gynecol. Scand., 63:577-579, (1984).
Dennerstein et al., British Medical Journal, vol. 290, pp. 1617-1621, Jun. 1, 1985.
Reid and Yen, Am. J. Obstet.Gynecol., vol. 139, No. 1, pp. 85-104 (1981), at 87.
Hargrove Joel T.
Maxson Wayne S.
Meyers Philip G.
LandOfFree
Method for treatment of premenstrual syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of premenstrual syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of premenstrual syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849968